Sort
48,018 grants matching “immunotherapy”
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$493,581Benjamin W. Purow · University Of Virginia · R01 · FY2014 · CA
Novel DGKalpha inhibitors and immunotherapy for GBM and melanoma brain metastasis
$493,581Benjamin W. Purow · University Of Virginia · R01 · FY2015 · CA
Exploiting a novel regulator of immunometabolism to enhance immunotherapy
$493,535Edward John Usherwood · Dartmouth College · R01 · FY2025 · CA
Exploiting a novel regulator of immunometabolism to enhance immunotherapy
$493,535Edward John Usherwood · Dartmouth College · R01 · FY2022 · CA
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy
$493,522Weiqiang Chen · New York University · R01 · FY2024 · CA
Evaluation of Immune-based Combinations in Prostate Cancer
$493,445Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Neoadjuvant checkpoint blockade for recurrent glioblastoma
$493,424Robert M Prins · University Of California Los Angeles · R01 · FY2025 · CA
Measuring and Modulating Oxidative DNA Damage Surveillance Pathways
$493,411Eric T. Kool · Stanford University · R01 · FY2020 · CA
Defining the role of innate immune cells in the early stages of immune surveillance of skin cancer by using a novel model that allows in vivo imaging of the immunoediting process.
$493,397Dennis Roop · University Of Colorado Denver · R01 · FY2024 · AR
Biomaterials for modulating the gut microbiome for immune activation
$493,392James J. Moon · University Of Michigan At Ann Arbor · R01 · FY2022 · CA
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
$493,176Jin Chen · Vanderbilt University Medical Center · R01 · FY2021 · CA
Effect of tumor cell glutamine metabolism on anti-tumor immunity in TNBC
$493,176Jin Chen · Vanderbilt University Medical Center · R01 · FY2020 · CA
Effects of FLASH Radiation on Cancer and the Immune Response
$493,013Edgar G. Engleman · Stanford University · R01 · FY2019 · CA
Effects of FLASH Radiation on Cancer and the Immune Response
$493,013Edgar G. Engleman · Stanford University · R01 · FY2020 · CA
Effects of FLASH Radiation on Cancer and the Immune Response
$493,013Edgar G. Engleman · Stanford University · R01 · FY2021 · CA
Novel CART Cells for Treating AML
$493,002Xianxin Hua · University Of Pennsylvania · R01 · FY2024 · CA
Role of Tspan5 in MHC I antigen presentation and cancer immune evasion
$492,997Kenneth L Rock · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Determining the interplay of MAIT cells and the translocated microbiome in HIV-induced neuroinflammation
$492,992Dominic Paquin-Proulx · Henry M. Jackson Fdn For The Adv Mil/Med · R21 · FY2023 · MH
A microfluidics-based paradigm for clinical lentivector gene transfer
$492,987Wilbur A Lam · Emory University · R01 · FY2019 · HL
Targeting age-related neuroinflammation and postoperative cognitive decline: a microbial-based approach
$492,985Laura K Fonken · University Of Texas At Austin · R01 · FY2020 · AG
Enhancing Adoptive Immunotherapy Targeting Pediatric High-Grade Gliomas
$492,969Duane A. Mitchell · University Of Florida · R01 · FY2016 · CA
Promoting immunity against acute myeloid leukemia through Fc effector-optimized antibody inhibitory of MICA/B shedding
$492,841Lucas Ferrari De Andrade · Icahn School Of Medicine At Mount Sinai · R37 · FY2023 · CA
The Adenosinergic Pathway in Tumor-derived Exosomes
$492,737Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Lineage heterogeneity and plasticity in lung cancer
$492,674Hideo Watanabe · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA
Characterizing head and neck tumor neoantigensand T cells: looking beyond the usual suspects
$492,627John B Sunwoo · Stanford University · R01 · FY2020 · DE